NPPB and childhood malignant neoplasm: In the study of Mavinkurve-Groothius et al.[26], abnormal levels of NTproBNP were detected in 13% of 122 asymptomatic survivors of childhood cancer who had received a median cumulative ANT dose comparable to our study.